Contents

Current Drug Targets, Volume 6 - Number 4

Editorial [Hot Topic: Galectin-1 as an Essential Factor in Nervous System (Guest Editor: Hidenori Horie)]

, 6(4): 373 - 374

Hidenori Horie


DOI: 10.2174/1389450054021936




Structural and Functional Studies of Galectin-1: A Novel Axonal Regeneration-Promoting Activity for Oxidized Galectin-1

, 6(4): 375 - 383

Toshihiko Kadoya and Hidenori Horie


DOI: 10.2174/1389450054022007




Oxidized Galectin-1 is an Essential Factor for Peripheral Nerve Regeneration

, 6(4): 385 - 394

Hidenori Horie, Toshihiko Kadoya, Kazunori Sango and Mitsuhiro Hasegawa


DOI: 10.2174/1389450054021954




Galectin-1 is a Novel Factor that Regulates Myotube Growth in Regenerating Skeletal Muscles

, 6(4): 395 - 405

Katsuya Kami and Emiko Senba


DOI: 10.2174/1389450054021918




Galectin-1 as a Potential Therapeutic Agent for Amyotrophic Lateral Sclerosis

, 6(4): 407 - 418

T. Kato, C.- H. Ren, M. Wada and T. Kawanami


DOI: 10.2174/1389450054021846




Expression and Functions of Galectin-1 in Sensory and Motoneurons

, 6(4): 419 - 425

A. D. Gaudet, J. D. Steeves, W. Tetzlaff and M. S. Ramer


DOI: 10.2174/1389450054021864




Glycans and Glycan-Binding Proteins in Brain: Galectin-1-Induced Expression of Neurotrophic Factors in Astrocytes

, 6(4): 427 - 436

Tamao Endo


DOI: 10.2174/1389450054021909




Regulation of the Neuronal Fate by ΔFosB and its Downstream Target, Galectin-1

, 6(4): 437 - 444

Tomofumi Miura, Yoshinori Ohnishi, Hideaki Kurushima, Hidenori Horie, Toshihiko Kadoya and Yusaku Nakabeppu


DOI: 10.2174/1389450054021963




Editorial [Hot Topic: Potential New Therapeutic Strategies of Diabetic Vascular Complications (Guest Editor: Toyoshi Inoguchi)]

, 6(4): 445 - 446

Toyoshi Inoguchi


DOI: 10.2174/1389450054021945




Blockade of Diabetic Vascular Injury by Controlling of AGE-RAGE System

, 6(4): 447 - 452

Khin Mar Myint, Yasuhiko Yamamoto, Shigeru Sakurai, Ai Harashima, Takuo Watanabe, Hui Li, Akihiko Takeuchi, Kazunobu Yoshimura, Hideto Yonekura and Hiroshi Yamamoto


DOI: 10.2174/1389450054021882




The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease

, 6(4): 453 - 474

M. C. Thomas, J. W. Baynes, S. R. Thorpe and M. E. Cooper


DOI: 10.2174/1389450054021873




Aldose Reductase in Diabetic Microvascular Complications

, 6(4): 475 - 486

S. S.M. Chung and S. K. Chung


DOI: 10.2174/1389450054021891




Molecular Targets of Diabetic Cardiovascular Complications

, 6(4): 487 - 494

Fatima K. Ahmad, Zhiheng He and George L. King


DOI: 10.2174/1389450054021990




NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive β-Cell Dysfunction and Metabolic Syndrome

, 6(4): 495 - 501

Toyoshi Inoguchi and Hajime Nawata


DOI: 10.2174/1389450054021927




Molecular Targets of Diabetic Vascular Complications and Potential New Drugs

, 6(4): 503 - 509

Roberto Da Ros, Roberta Assaloni and Antonio Ceriello


DOI: 10.2174/1389450054021855




Vascular Endothelial Growth Factor and Diabetic Retinopathy: Role of Oxidative Stress

, 6(4): 511 - 524

Ruth B. Caldwell, Manuela Bartoli, M. Ali Behzadian, Azza E.B. El-Remessy, Mohamed Al-Shabrawey, Daniel H. Platt, Gregory I. Liou and R. William Caldwell


DOI: 10.2174/1389450054021981




Adipokines: Therapeutic Targets for Metabolic Syndrome

, 6(4): 525 - 529

Kunihisa Kobayashi and Toyoshi Inoguchi


DOI: 10.2174/1389450054021972




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science